Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility
Launched by AHMED WALID ANWAR MURAD · Mar 5, 2018
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
A prospective randomized study included 210 patients with Unexplained infertility subjected to coupled ovarian stimulation and Intrauterine insemination (IUI). Two equal groups. Study group, subjected to uterine flushing with Human chorionic gonadotropin (HCG) one day before IUI and control group subjected to IUI alone.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Unexplained infertility (UI)
- Exclusion Criteria:
- • body mass index (BMI) ≥35 kg/m2,
- • Follicle Stimulating Hormone \>10 International Unit /Litter in early follicular phase,
- • diagnosed cause of infertility, menstrual cycle irregularity,
- • ovarian cysts,
- • sever cervical stenosis,
- • former IUI,
- • ongoing pregnancy and
- • renal or hepatic diseases were all the exclusion criteria.
About Ahmed Walid Anwar Murad
Ahmed Walid Anwar Murad is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, he oversees the planning, execution, and monitoring of clinical trials across various therapeutic areas. His extensive experience in clinical research, combined with a strong emphasis on regulatory compliance and ethical standards, ensures that trials are conducted with the highest level of integrity and scientific rigor. Through collaboration with healthcare professionals and research institutions, Ahmed aims to contribute to the development of effective treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials